Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ulanhot Zhongmeng Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and production of Traditional Mongolian Medicine (TMM). Originally founded as a state-owned factory in 1970 and restructured in 1999, the company is recognized as a key enterprise in the modernization of ethnic minority medicine within the Inner Mongolia Autonomous Region. Its portfolio includes over 140 varieties of Mongolian medicines across multiple dosage forms, including pills, tablets, and capsules. The company's flagship products, such as Red Flower Clear Liver Pills, are widely utilized for the treatment of liver and gallbladder diseases. Ulanhot Zhongmeng Pharmaceutical operates modern GMP-certified manufacturing facilities and maintains a strong focus on integrating traditional formulas with modern clinical research and industrial standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ulanhot Zhongmeng Pharmaceutical.